Login Register Cart 0
Generic placeholder image

Current Analytical Chemistry

Editor-in-Chief

ISSN (Print): 1573-4110
ISSN (Online): 1875-6727

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Eco-Friendly Green Liquid Chromatographic Separations of a Novel Combination of Azelastine and Fluticasone in the Presence of their Pharmaceutical Dosage form Additives

Author(s): Amal A. El-Masry, Mohammed E. A. Hammouda*, Dalia R. El-Wasseef and Saadia M. El-Ashry

Volume 16, Issue 3, 2020

Page: [277 - 286] Pages: 10

DOI: 10.2174/1573411014666180727130722

Price: $65

Abstract

Background: The first highly sensitive, rapid and specific green microemulsion liquid chromatographic (MELC) method was established for the simultaneous estimation of fluticasone propionate (FLU) and azelastine HCl (AZL) in the presence of their pharmaceutical dosage form additives (phenylethyl alcohol (PEA) and benzalkonium chloride (BNZ)).

Methods: The separation was performed on a C18 column using (o/w) microemulsion as a mobile phase which contains 0.2 M sodium dodecyl sulphate (SDS) as surfactant, 10% butanol as cosurfactant, 1% n-octanol as internal phase and 0.3% triethylamine (TEA) adjusted at pH 6 by 0.02 M phosphoric acid; with UV detection at 220 nm and programmed with flow rate of 1 mL/min.

Results: The validation characteristics e.g. linearity, lower limit of quantification (LOQ), lower limit of detection (LOD), accuracy, precision, robustness and specificity were investigated. The proposed method showed linearity over the concentration range of (0.5-25 µg/mL) and (0.1-25 µg/mL) for FLU and AZL, respectively. Besides that, the method was adopted in a short chromatographic run with satisfactory resolution factors of (2.39, 3.78 and 6.74 between PEA/FLU, FLU/AZL and AZL/BNZ), respectively. The performed method was efficiently applied to pharmaceutical nasal spray with (mean recoveries ± SD) (99.80 ± 0.97) and (100.26 ± 0.96) for FLU and AZL, respectively.

Conclusion: The suggested method was based on simultaneous determination of FLU and AZL in the presence of PEA and BNZ in pure form, laboratory synthetic mixture and its combined pharmaceutical dosage form using green MELC technique with UV detection. The proposed method appeared to be superior to the reported ones of being more sensitive and specific, as well as the separation was achieved with good performance in a relatively short analysis time (less than 7.5 min). Highly acceptable values of LOD and % RSD make this method superior to be used in quality control laboratories with of HPLC technique.

Keywords: Azelastine HCl (AZL), Benzalkonium chloride (BNZ), Fluticasone propionate (FLU), green Microemulsion Liquid Chromatography (MELC), HPLC, nasal spray, Phenylethyl Alcohol (PEA).

« Previous Next »
Graphical Abstract

[1]
British Pharmacopoeia; Her Majesty's Stationary Office: London, 2014.
[2]
Reynolds, J.E.F. The extra pharmacopoeia, 37th ed; Pharmaceutical Press: London, 2011.
[3]
Berger, W.E.; Bernstein, J.A.; Meltzer, E.O.; Ratner, P.H.; Ruiz, N. Efficacy of azelastine HCl/Fluticasone propionate nasal spray in the treatment of nasal congestion in patients with Seasonal Allergic Rhinitis (SAR). J. Allergy Clin. Immunol., 2015, 135(2), AB219.
[http://dx.doi.org/10.1016/j.jaci.2014.12.1649]
[4]
El-Masry, A.A.; Hammouda, M.E.A.; El-Wasseef, D.R.; El-Ashry, S.M. Validated spectroscopic methods for determination of anti-histaminic drug azelastine in pure form: Analytical application for quality control of its pharmaceutical preparations. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2018, 191, 413-420.
[http://dx.doi.org/10.1016/j.saa.2017.10.049] [PMID: 29065333]
[5]
Gouda, A.A.; El Sheikh, R.; El Saied, H. Extractive spectrophotometric determination of azelastine hydrochloride in pure form and pharmaceutical formulations. Can. Chem. Trans., 2015, 3(1), 29-41.
[6]
El-Masry, A.A.; Hammouda, M.E.; El-Wasseef, D.R.; El-Ashry, S.M. Validated sensitive spectrofluorimetric method for determination of antihistaminic drug azelastine HCl in pure form and in pharmaceutical dosage forms: application to stability study. Luminescence, 2017, 32(2), 177-181.
[http://dx.doi.org/10.1002/bio.3164] [PMID: 27279096]
[7]
Abdel-Razeq, S.A.; Foaud, M.M.; Salama, N.N.; Abdel-Atty, S.; El-Kosy, N. Voltammetric determination of azelastine-HCl and emedastine difumarate in micellar solution at glassy carbon and carbon paste electrodes. Sens. Electroanal., 2011, 6, 289-305.
[8]
Elghobashy, M.R.; Badran, O.M.; Salem, M.Y.; Kelani, K.M. Application of membrane selective electrodes for the determination of azelastine hydrochloride in the presence of its alkaline degradant in eye drops and plasma. Anal. Bioanal. Electrochem., 2013, 5(3), 325-340.
[9]
Salama, N.N.; Abdel-Razeq, S.A.; Abdel-Atty, S.; El-Kosy, N. Development and validation of densitometry TLC stability indicating a method for quantitative determination of azelastine hydrochloride and emedastine difumarate in their drug products. Br. J. Pharm. Res., 2014, 4(1), 79-92.
[http://dx.doi.org/10.9734/BJPR/2014/3693]
[10]
Thangabalan, B.; Kumar, P.V. RP-HPLC determination of azelastine in pure form and in the ophthalmic formulation. Int. J. Pharm. Sci. Rev. Res., 2012, 17(2), 62-64.
[11]
El-Shaheny, R.N.; Yamada, K. Stability study of the antihistamine drug azelastine HCl along with a kinetic investigation and the identification of new degradation products. Anal. Sci., 2014, 30(6), 691-697.
[http://dx.doi.org/10.2116/analsci.30.691] [PMID: 24919676]
[12]
Sane, R.; Joshi, S.; Francis, M.; Khatri, A.; Hijli, P. High-performance thin-layer chromatographic determination of azelastine hydrochloride. J. Planar Chromatogr. Mod. TLC, 1999, 12(2), 158-160.
[13]
Park, Y-S.; Kim, S-H.; Kim, Y-J.; Yang, S.C.; Lee, M.H.; Shaw, L.M.; Kang, J.S. Determination of azelastine in human plasma by validated liquid chromatography coupled to Tandom Mass Spectrometry (LC-ESI/MS/MS) for the clinical studies. Int. J. Biomed. Sci., 2010, 6(2), 120-127.
[PMID: 23675185]
[14]
Heinemann, U.; Blaschke, G.; Knebel, N. Simultaneous enantioselective separation of azelastine and three of its metabolites for the investigation of the enantiomeric metabolism in rats. I. Liquid chromatography-ionspray tandem mass spectrometry and electrokinetic capillary chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2003, 793(2), 389-404.
[http://dx.doi.org/10.1016/S1570-0232(03)00357-X] [PMID: 12906914]
[15]
Kondawar, M.; Shah, R.; Waghmare, J.; Malusare, M.; Shah, N. UV spectrophotometric method for simultaneous estimation of Salmeterol xinafoate and Fluticasone propionate in bulk and dosage form. Int. J. Pharm. Tech. Res., 2011, 3(3), 1801-1806.
[16]
Samir, A.; Salem, H.; Abdelkawy, M. New developed a spectrophotometric method for simultaneous determination of salmeterol xinafoate and fluticasone propionate in bulk powder and Seritide diskus inhalation. Bull. Fac. Pharm. Cairo Univ., 2012, 50(2), 121-126.
[http://dx.doi.org/10.1016/j.bfopcu.2012.07.006]
[17]
Samir, A.; Salem, H.; Abdelkawy, M. Simultaneous determination of salmeterol xinafoate and fluticasone propionate in bulk powder and seritidediskus using high performance liquid chromatographic and spectrophotometric method. Pharm. Anal. Acta, 2012, 3(8), 1.
[http://dx.doi.org/10.4172/2153-2435.1000180]
[18]
Duran, A.; Dogan, H.N.; Ulgen, M. Simultaneous quantitative determinations of fluticasone propionate and salmeterol xinafote in diskus inhalers. Drug Metab. Lett., 2014, 8(1), 31-35.
[http://dx.doi.org/10.2174/187231280801140929161136] [PMID: 25313021]
[19]
Esmaeilpour, H. A validated HPLC method for determining of inhaler residues on pharmaceutical manufacturing equipment surfaces. Res. Pharm. Sci., 2012, 7(5), S697.
[20]
Pączkowska, E.; Smukowska, D.; Tratkiewicz, E.; Białasiewicz, P. HPLC method for simultaneous determination of salmeterol xinafoate and fluticasone propionate for the quality control of dry powder inhalation products. Acta Chromatogr., 2014, 27(2), 309-320.
[http://dx.doi.org/10.1556/AChrom.27.2015.2.8]
[21]
Kasaye, L.; Hymete, A.; Mohamed, A-M.I. HPTLC-densitometric method for simultaneous determination of salmeterol xinafoate and fluticasone propionate in dry powder inhalers. Saudi Pharm. J., 2010, 18(3), 153-159.
[http://dx.doi.org/10.1016/j.jsps.2010.05.001] [PMID: 23964174]
[22]
Dave, H.N.; Makwana, A.G.; Bhatt, C.; Pundarikakshudu, K. Validated HPTLC method for the determination of two novel steroids in bulk and pressurized metered-dose preparations. Int. J. Appl. Sci. Eng., 2011, 9(3), 177-185.
[23]
Buscher, B.A.; Jägfeldt, H.; Sandman, H.; Brust-van Schaik, R.; van Schaik, F.; Brüll, L.P. The determination of budesonide and fluticasone in human sputum samples collected from COPD patients using LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2012, 880(1), 6-11.
[http://dx.doi.org/10.1016/j.jchromb.2011.10.029] [PMID: 22169057]
[24]
Silvestro, L.; Savu, S.R.; Savu, S.N.; Tudoroniu, A.; Tarcomnicu, I. Development of a sensitive method for simultaneous determination of fluticasone propionate and salmeterol in plasma samples by liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr., 2012, 26(5), 627-635.
[http://dx.doi.org/10.1002/bmc.1708] [PMID: 22577660]
[25]
Sangoi, Mda.S.; Wrasse, M.; D’Avila, F.B.; Bernardi, R.M.; de Oliveira, P.R.; Dalmora, S.L.; Bueno Rolim, C.M. A high-throughput liquid chromatography tandem mass spectrometry method for the comparative determination of fluticasone propionate by reversed-phase liquid chromatography and capillary electrophoresis methods in pharmaceutical nasal sprays. Eur J Mass Spectrom (Chichester), 2009, 15(6), 723-730.
[http://dx.doi.org/10.1255/ejms.1044] [PMID: 19940338]
[26]
Sangoi, Mda.S.; da Silva, L.M.; D’Avila, F.B.; Dalmora, S.L. Determination of fluticasone propionate in nasal sprays by a validated stability-indicating MEKC method. J. Chromatogr. Sci., 2010, 48(8), 641-646.
[http://dx.doi.org/10.1093/chromsci/48.8.641] [PMID: 20819293]
[27]
Patel Rina, B.; Patel Bhavika, B.; Thakkar Hiren, S.; Patel Pinkal, R.; Patel Nilam, K.; Patel Shirish, R. Development and Validation of First Order Derivative spectrophotometric method for simultaneous estimation of fluticasone propionate and Azelastine hydrochloride in nasal spray preparations. Pharm. Anal. Qual. Assur, 2013.
[28]
Merey, H.A.; El-Mosallamy, S.S.; Hassan, N.Y.; El-Zeany, B.A. Simultaneous determination of Fluticasone propionate and Azelastine hydrochloride in the presence of pharmaceutical dosage form additives. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2016, 160, 50-57.
[http://dx.doi.org/10.1016/j.saa.2016.02.010] [PMID: 26921606]
[29]
Rao, K.L.N.; Reddy, K.P.; Babu, K.S.; Raju, K.S.; Rao, K.V.; Shaik, J.V. Simultaneous Estimation of Fluticasone propionate, Azelastine Hydrochloride, Phenylethyl alcohol and Benzalkonium chloride by RP-HPLC Method in Nasal spray preparations. International Journal of Research in Pharmaceutical Science, 2010, 1(4), 473-480.
[30]
Harmonized Tripartite Guideline, I.C.H. Validation of Analytical Procedures: Text and Methodology, Q2(R1), Current Step 4 Version, Parent Guidelines on Methodology Dated November 6 (1996); , Incorporated in November. 2005.
[31]
Miller, J.N.; Miller, J.C.B. Statistics and chemometrics for analytical chemistry, 5th Ed; Pearson Education Limited: Harlow, England, 2005, p. 256.

Rights & Permissions Print Cite
Article Metrics
11
© 2024 Bentham Science Publishers | Privacy Policy